180 Poster - Early evidence of dose-dependent pharmacodynamic activity following treatment with SY-5609, a highly selective and potent oral CDK7 inhibitor, in patients with advanced solid tumors.

Subjects

Subjects :

*THERAPEUTIC use of antineoplastic agents
*CONFERENCES & conventions
*TRANSFERASES
*TUMORS

Details

Language :

English

ISSN :

09598049

Volume :

138

Database :

Academic Search Index

Journal :

European Journal of Cancer

Publication Type :

Academic Journal

Accession number :

148120323

Full Text :

https://doi.org/10.1016/S0959-8049(20)31211-9